| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3015618 | Revista Española de Cardiología | 2007 | 11 Pages |
Abstract
The survival rates obtained in Spain with HT, especially in recent years, ensure that HT is the treatment of choice for patients with end-stage heart failure and a poor functional status. There are no other well-established medical or surgical alternatives.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Luis Almenar-Bonet, en representación de los Grupos Españoles de Trasplante Cardiaco en representación de los Grupos Españoles de Trasplante Cardiaco,